ADRINEH PKHRIKYAN: Open Payments
NPI 1770273666 · RESEDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,827 in 62 payments from 13 companies in 2025. Trend: 2023 $484 · 2024 $2,252 · 2025 $1,827
Food & beverage: $1,827
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 16 | $877 |
| Novartis Pharmaceuticals Corporation | 12 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $159 |
| Amgen Inc. | 8 | $149 |
| CVRx, Inc. | 4 | $127 |
| Merck Sharp & Dohme LLC | 4 | $108 |
| Medtronic, Inc. | 2 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| HEARTFLOW, INC. | 2 | $38 |
Products named: GALLANT, JOT DX, AVEIR, LEQVIO, REPATHA, Adempas, Barostim Neo System, VERQUVO.
Industry payments across CA — which companies pay providers there.
